I now have comprehensive information from multiple authoritative textbooks. Let me compile the full response.
Hormonal Regulation of Blood Glucose Levels
Blood glucose (plasma glucose) is tightly maintained between 70-100 mg/dL (fasting) through a coordinated interplay of hormones, neural signals, and substrate effects. This is called glucose homeostasis or metabolic homeostasis.
- Basic Medical Biochemistry - A Clinical Approach, 6e, p. 694
- Biochemistry (Lippincott), 8e, p. 877
- Harrison's Principles of Internal Medicine, 22E, p. 3275
1. Overview: The Principal Hormones
| Hormone | Source | Net Effect on Blood Glucose |
|---|
| Insulin | Pancreatic β-cells | Decreases (hypoglycemic) |
| Glucagon | Pancreatic α-cells | Increases (hyperglycemic) |
| Epinephrine | Adrenal medulla | Increases (hyperglycemic) |
| Cortisol | Adrenal cortex | Increases (slow, transcriptional) |
| Growth hormone | Anterior pituitary | Increases (slow, transcriptional) |
The ratio of insulin to glucagon is what most directly controls blood glucose at any moment.
2. Insulin - The Anabolic Hypoglycemic Hormone
Source and Structure
Insulin is a polypeptide synthesized as proinsulin in the β-cells of the islets of Langerhans. Proinsulin is cleaved into mature insulin and C-peptide in storage vesicles. C-peptide is released in equimolar amounts with insulin and can be used as a clinical marker of endogenous insulin secretion.
Stimuli for Insulin Secretion
- Elevated blood glucose (primary stimulus) - glucose enters β-cells via GLUT-2 transporters
- Amino acids (especially arginine, leucine)
- GI hormones (GLP-1, GIP - incretin effect)
- Vagal stimulation (anticipatory, cephalic phase)
- Sulfonulyureas (pharmacologic, block K-ATP channels)
Mechanism of Glucose-Stimulated Insulin Secretion
Glucose enters β-cells → undergoes glycolysis → raises the ATP/ADP ratio → closes K-ATP channels → cell membrane depolarizes → voltage-gated Ca²⁺ channels open → Ca²⁺ influx → exocytosis of insulin granules.
Biphasic response:
- First phase - rapid, from pre-formed granules docked at the membrane; impaired early in type 2 diabetes
- Second phase - sustained, from deeper vesicles + newly synthesized insulin
Mechanism of Action
Insulin binds its receptor tyrosine kinase on target cell surfaces → autophosphorylation of the receptor → downstream phosphorylation cascades → promotes dephosphorylation of key metabolic enzymes (opposite to glucagon/cAMP-PKA effects).
Key effector: translocation of GLUT-4 to cell membranes in muscle and adipose tissue, greatly increasing glucose uptake.
Metabolic Effects of Insulin (Fed/Anabolic State)
In the liver:
- Promotes glycogen synthesis (activates glycogen synthase, inhibits glycogen phosphorylase)
- Promotes glycolysis and inhibits gluconeogenesis
- Promotes triglyceride synthesis (promotes lipogenesis)
- Inhibits ketogenesis
In skeletal muscle:
- Promotes glucose uptake via GLUT-4
- Promotes glycogen synthesis
- Promotes protein synthesis
In adipose tissue:
- Promotes glucose uptake via GLUT-4
- Promotes triglyceride synthesis and storage
- Inhibits hormone-sensitive lipase (anti-lipolytic)
Other effects:
- Promotes K⁺ uptake into cells (Na⁺-K⁺ ATPase activation) - clinically used in hyperkalemia treatment
- Promotes cell growth and protein synthesis
Insulin directs glucose into the liver for storage - Basic Medical Biochemistry, 6e
3. Glucagon - The Catabolic Hyperglycemic Hormone
Source and Stimuli for Secretion
- Low blood glucose (primary stimulus) - overnight or prolonged fasting
- Amino acids (arginine) from a protein meal - prevents hypoglycemia that would otherwise follow the insulin response to that meal
- Catecholamines (epinephrine, norepinephrine via sympathetic innervation) - especially during physiologic stress
Glucagon secretion is suppressed by: elevated blood glucose and by insulin (both rise after a carbohydrate meal).
Mechanism of Action
Glucagon binds G protein-coupled receptors (GPCRs) on hepatocyte membranes → activates adenylyl cyclase → raises cAMP → activates Protein Kinase A (PKA) → phosphorylation of key regulatory enzymes.
Glucagon signaling cascade - Basic Medical Biochemistry, 6e
Metabolic Effects of Glucagon (Fasting/Catabolic State)
Carbohydrate metabolism (primary target: liver):
- Stimulates glycogenolysis (glycogen → glucose-1-phosphate → glucose)
- Stimulates gluconeogenesis (from amino acids, lactate, glycerol)
- Inhibits glycolysis (reduces PFK-1 activator fructose 2,6-bisphosphate)
- Daytime blood glucose maintained mainly by glycogenolysis; as the overnight fast lengthens, glycogen stores fall and gluconeogenesis becomes the dominant contributor
Lipid metabolism:
- Stimulates lipolysis in adipose tissue (via protein kinase A activation of hormone-sensitive lipase)
- Inhibits fatty acid synthesis (phosphorylates and inactivates ACC)
- Removes inhibition on CPT-1, enabling fatty acid β-oxidation and ketogenesis
Protein metabolism:
- Increases hepatic uptake of amino acids from muscle → carbon skeletons for gluconeogenesis
4. The Insulin-Glucagon Tug-of-War
The opposing actions of these hormones on hepatic metabolism are shown below. Insulin turns on glycolysis, glycogenesis, and lipogenesis; glucagon + epinephrine turn on glycogenolysis, gluconeogenesis, ketogenesis, and lipolysis.
Opposing actions of insulin vs. glucagon and epinephrine - Biochemistry (Lippincott), 8e
5. Counterregulatory Hormones
When blood glucose falls below the physiologic range, a hierarchical set of counterregulatory responses is activated. According to Harrison's (22E), the glycemic thresholds and response hierarchy are:
| Glycemic Threshold | Response | Role |
|---|
| ~4.4-4.7 mmol/L (80-85 mg/dL) | ↓ Insulin secretion | First defense - increases hepatic glucose output |
| Just below physiologic range | ↑ Glucagon secretion | Primary counterregulatory response - stimulates glycogenolysis + gluconeogenesis |
| ~3.8 mmol/L (~68 mg/dL) | ↑ Epinephrine (adrenal medulla) | Critical when glucagon deficient (e.g., late type 1 DM) |
| Below ~3.3 mmol/L (~60 mg/dL) | Cognitive impairment (CNS symptoms) | Neuroglycopenia |
| Prolonged (>4 hours) hypoglycemia | ↑ Cortisol, ↑ Growth hormone | Slow (transcriptional), minor acute role |
Epinephrine
- Stimulates hepatic glycogenolysis AND gluconeogenesis
- Stimulates renal gluconeogenesis
- Inhibits insulin secretion (preventing GLUT-4-mediated muscle/adipose uptake)
- Stimulates lipolysis → provides glycerol + fatty acids (gluconeogenic substrate + alternative fuel)
- Binds β-adrenergic receptors on liver/muscle (note: epinephrine receptors differ from glucagon receptors and are also present on skeletal muscle, whereas glucagon receptors are not)
Cortisol
- Stimulates gluconeogenesis (permissive effects via gene transcription)
- Promotes protein catabolism in muscle → provides amino acid precursors
- Antagonizes insulin action in peripheral tissues (insulin resistance)
- Acts slowly (hours-days); no meaningful role in acute hypoglycemia defense
Growth Hormone
- Stimulates lipolysis (provides fatty acids as alternative fuel, spares glucose)
- Inhibits insulin-stimulated glucose uptake in peripheral tissues
- Like cortisol, plays a role in prolonged (not acute) hypoglycemia
Physiology of glucose counterregulation - Harrison's Principles of Internal Medicine, 22E
6. Postprandial vs. Fasting States Summary
| State | Key Hormones | Key Metabolic Events |
|---|
| Fed / Postprandial | High insulin, Low glucagon | ↑ Glucose uptake (GLUT-4), ↑ Glycogenesis, ↑ Lipogenesis, ↑ Protein synthesis |
| Early fasting (2-4 h) | Low insulin, High glucagon | Hepatic glycogenolysis → maintains blood glucose |
| Prolonged fasting (overnight) | Very low insulin, High glucagon | Gluconeogenesis increases (supplies ~60-70% of hepatic glucose output); lipolysis; ketogenesis |
| Stress / exercise | Catecholamines + glucagon dominant | Rapid glycogenolysis, lipolysis, gluconeogenesis; insulin suppressed |
7. Clinical Correlations
| Condition | Hormonal Disturbance | Result |
|---|
| Type 1 diabetes | Absolute insulin deficiency | Hyperglycemia, DKA, K⁺ shifts (hyperkalemia) |
| Type 2 diabetes | Insulin resistance + relative deficiency; impaired 1st-phase secretion | Hyperglycemia, dyslipidemia |
| Insulinoma | Excess insulin (tumor) | Fasting hypoglycemia (Whipple's triad) |
| Hypoglycemia in late T1DM | Absent glucagon + blunted epinephrine response | Loss of counterregulation → severe hypoglycemia unawareness |
| Glucagonoma | Excess glucagon | Hyperglycemia + necrolytic migratory erythema |
| Cushing's syndrome | Excess cortisol | Insulin resistance, hyperglycemia |
Key takeaway: Blood glucose regulation is a dynamic balance between insulin (the single hypoglycemic hormone) and multiple hyperglycemic counterregulatory hormones (glucagon, epinephrine, cortisol, growth hormone). Glucagon is the mirror-image of insulin and is the primary counterregulatory hormone; epinephrine becomes critical as a backup; cortisol and growth hormone act slowly and play no role in acute hypoglycemia defense.